These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1345 related articles for article (PubMed ID: 12680238)

  • 1. Anticancer potential of curcumin: preclinical and clinical studies.
    Aggarwal BB; Kumar A; Bharti AC
    Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
    López-Lázaro M
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
    Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
    Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin as "Curecumin": from kitchen to clinic.
    Goel A; Kunnumakkara AB; Aggarwal BB
    Biochem Pharmacol; 2008 Feb; 75(4):787-809. PubMed ID: 17900536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
    Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
    Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.
    Goel A; Aggarwal BB
    Nutr Cancer; 2010; 62(7):919-30. PubMed ID: 20924967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin: getting back to the roots.
    Shishodia S; Sethi G; Aggarwal BB
    Ann N Y Acad Sci; 2005 Nov; 1056():206-17. PubMed ID: 16387689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
    Kunnumakkara AB; Anand P; Aggarwal BB
    Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin and its analogues: potential anticancer agents.
    Agrawal DK; Mishra PK
    Med Res Rev; 2010 Sep; 30(5):818-60. PubMed ID: 20027668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
    Anand P; Sundaram C; Jhurani S; Kunnumakkara AB; Aggarwal BB
    Cancer Lett; 2008 Aug; 267(1):133-64. PubMed ID: 18462866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
    Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
    Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.
    Shankar S; Srivastava RK
    Carcinogenesis; 2007 Jun; 28(6):1277-86. PubMed ID: 17277231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer potential of silymarin: from bench to bed side.
    Agarwal R; Agarwal C; Ichikawa H; Singh RP; Aggarwal BB
    Anticancer Res; 2006; 26(6B):4457-98. PubMed ID: 17201169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin: the Indian solid gold.
    Aggarwal BB; Sundaram C; Malani N; Ichikawa H
    Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
    Einbond LS; Wu HA; Kashiwazaki R; He K; Roller M; Su T; Wang X; Goldsberry S
    Fitoterapia; 2012 Oct; 83(7):1160-8. PubMed ID: 22828666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
    Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
    Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.